Abstract: The present invention is directed to topical enzymatic wound debriding compositions with enhanced enzymatic activity. These compositions comprise a dispersed phase comprising at least one proteolytic enzyme and at least one hydrophilic polyol; and a continuous phase comprising a hydrophobic base.
| # | Name | Date |
|---|---|---|
| 1 | 5269-DELNP-2012.pdf | 2012-07-09 |
| 2 | 5269-delnp-2012-GPA-(16-07-2012).pdf | 2012-07-16 |
| 3 | 5269-delnp-2012-Correspondence-Others-(16-07-2012).pdf | 2012-07-16 |
| 4 | 5269-delnp-2012-Assignment-(16-07-2012).pdf | 2012-07-16 |
| 5 | 5269-delnp-2012-Form-3-(17-12-2012).pdf | 2012-12-17 |
| 6 | 5269-delnp-2012-Correspondence others-(17-12-2012).pdf | 2012-12-17 |
| 7 | 5269-delnp-2012-GPA-(01-11-2013).pdf | 2013-11-01 |
| 8 | 5269-delnp-2012-Form-2-(01-11-2013).pdf | 2013-11-01 |
| 9 | 5269-delnp-2012-Correspondence-Others-(01-11-2013).pdf | 2013-11-01 |
| 10 | 5269-delnp-2012-Assignment-(01-11-2013).pdf | 2013-11-01 |
| 11 | 5269-delnp-2012-Form-18-(02-12-2013).pdf | 2013-12-02 |
| 12 | 5269-delnp-2012-Correspondence Others-(02-12-2013).pdf | 2013-12-02 |
| 13 | 5269-DELNP-2012-Form 3-051214.pdf | 2014-12-13 |
| 14 | 5269-DELNP-2012-Correspondence-051214.pdf | 2014-12-13 |
| 15 | 5269-DELNP-2012-FER.pdf | 2018-03-15 |
| 16 | 5269-DELNP-2012-AbandonedLetter.pdf | 2019-01-28 |
| 1 | searchstrategy5269DELNP2012_14-03-2018.pdf |